NovaBridge Biosciences (NBP) Net Margin (2020 - 2023)
NovaBridge Biosciences (NBP) reported Net Margin of 10557.46% for Q3 2023, down 97.25% on a QoQ basis from 384335.79% in Q4 2020.
NovaBridge Biosciences (NBP) has 2 years of Net Margin data on file, last reported at 10557.46% in Q3 2023.
- Quarterly Net Margin changed N/A year-over-year to 10557.46% in Q3 2023, while the trailing twelve-month figure through Sep 2023 was 1650.51% (changed N/A YoY) and the FY2023 annual result came in at 5376.85%, up 1806132.0% from the prior year.
- Net Margin slipped to 10557.46% in Q3 2023 per NBP's latest filing, from 384335.79% in the prior quarter.
- Across five years, Net Margin topped out at 384335.79% in Q4 2020 and bottomed at 10557.46% in Q3 2023.
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 10,557.46% |
| Dec 31, 2020 | 384,335.79% |